Scoopfeeds — Intelligent news, curated.
MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
business

MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy

Yahoo Finance · Jun 5, 2026, 9:56 PM

MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy

Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop